The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia

International Clinical Psychopharmacology

Volumn 15, Issue 1, 2000, Pages 43-48

  Ballus C ^a   Quiros, G ^b   de Flores, T ^c   De la Torre, J ^d   Palao, D ^e   Rojo, L ^f   Gutierrez M ^g   Casais, L ^h   Riesgo, Y ⁱ  

^a HOSPITAL CLÍNIC   (Spain)

^b Resid Nuestra Senora de Covadonga   (Spain)

^c HOSPITAL GENERAL DE CATALUNYA   (Spain)

^d Hospital Cruz Roja   (Spain)

^e Centro de Salud Mental H Mollet   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g HOSPITAL TXAGORRITXU   (Spain)

^h UNIVERSITY OF CÁDIZ   (Spain)

ⁱ Ctra De Burgos   (Spain)

Author keywords

Dysthymia; Major depression; Paroxetine; Remission; Venlafaxine

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSTHYMIA; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; XEROSTOMIA;

EID: 0033965892     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015010-00007     Document Type: Article

References (31)

1. Clerc GE, Ruimy P, Verdeau-Pailles J, on behalf of the venlafaxine French Inpatient Study Group (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9:139-143.
2. Costa e Silva JA (1998) Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. J Clin Psychiatry 59:352-357.
3. Depression Guideline Panel (1993) Depression in Primary Care, vol. 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5. AHCPR Publication no. 93-0551. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.
4. Dierick M, Martin A, Ravizza L, Realini R (1996) A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuro-Psychopharmacol Biol Psychiatry 20:57-71.
5. Dunner DL, Hendrickson HE, Bea CJ, Budech CB (1997) Treatment of dysthymic disorder with venlafaxine. Biol Psychiatry 42:254S.
6. Guelfi JD, Wisemen RL (1995) Treatment of dysthymia with sertraline: a double-blind placebo-controlled trial of dysthymic patients without major depression. Eur Neuropsychopharmacol 5:289.
7. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, rev edn. DHEW Publication no. (ADM)76-338. Rockville, MD: National Institutes of Mental Health.
8. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
9. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55.
10. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. (1993) A randomized, double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 150:1169-1175.
11. Johnson J, Weissman MM, Klerman GI (1992) Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 267:1478-1483.
12. Keller MB, Harrison W, Fawcett J, et al. (1995) Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull 31:205-212.
13. Kessler RC, McGonagle KA, Zhao S, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
14. Kocsis JH, Fraces AJ, Voss C, Mann JJ, Mason BJ, Sweeney J (1988) Imipramine treatment for chronic depression. Arch Gen Psychiatry 45:253-257.
15. Kocsis JH, Friedman RA, Markowitz JC, et al. (1996) Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 53:769-774.
16. Kocsis JH, Zisook S, Davidson J, et al. (1997) Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 154:390-395.
17. Lecrubier Y, Bourin M, Moon CAL, et al. (1997) Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand 95:485-493.
18. Markowitz JC, Moran ME, Kocsis JH, Frances AJ (1992) Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord 24:63-71.
19. McPartlin GM, Reynolds A, Anderson C, Casoy J (1998) A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Prim Care Psychiatry 4:127-132.
20. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
21. Ortero A, Palau D, Martin LM, Gasto C (1998) Efficacy and tolerance of venlafaxine in the treatment of patients with dysthymia. Paper presented at the 21st CINP Congress; Glasgow, Scotland.
22. Poirier M-F, Boyer P (1999) Double-blind, randomized comparison of venlafaxine and paroxetine for treatment resistant depression. Br J Psychiatry 174:12-16.
23. Ravindran AV, Charbonneau Y, Zaharia MD, et al. (1998) Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia. J Psychiatry Neurosci 23:288-292.
24. Regier DA, Boyd JH, Burke JD Jr, et al. (1988) One-month prevalance of mental disorders in the United States: based on five Epidemiologie Catchment Area sites. Arch Gen Psychiatry 45:977-986.
25. Rush AJ, Thase ME (1997) Strategies and tactics in the treatment of chronic depression. J Clin Psychiatry 58 (Suppl 13):14-22.
26. Thase ME, Fava M, Halbreich U, et al. (1996) A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777-784.
27. Tylee A, Beaumont G, Bowden M, Reynolds A (1997) A double-blind, randomised, 12-week comparison study of the safety and efficacy of venlafaxine and fluoxetine in moderate to severe depression in general practice. Prim Care Psychiatry 3:51-58.
28. Versiani M, Amrein R, Stabl M, et al. (1997) Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled study. Int Clin Psychopharmacol 12:183-193.
29. Weissman MM, Klerman GL (1977) The chronic depressive in the community: unrecognized and poorly treated. Compr Psychiatry 18:523-532.
30. Weissman MM, Leaf PJ, Bruce ML, Floria L (1988) The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment. Am J Psychiatry 145:815-819.
31. Wells KB, Golding JM, Burnam MA (1988) Psychiatric disorders in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145:976-981.